XTORO is a New Chemical Entity that is FDA approved for the treatment of acute otitis externa, commonly known as "swimmer’s ear", caused by susceptible strains of Pseudomonas aeruginosa and ...

Fonseca is stepping up to deliver a new option, XTORO, which is approved by the US Food and Drug Administration (FDA) for the treatment of AOE. Finafloxacin, the active ingredient in XTORO ...

Fonseca Biosciences ("Fonseca") announced today an agreement with MerLion Pharmaceuticals GmbH granting Fonseca the exclusive rights to market and distribute XTORO ® (finafloxacin otic suspension ...

0.3% in the United States. Millions of Americans suffer from acute otitis externa (AOE), better known as swimmer’s ear. Fonseca is stepping up to deliver a new option, XTORO, which is approved by the ...

Fonseca Biosciences (“Fonseca”) announced today an agreement with MerLion Pharmaceuticals GmbH granting Fonseca the exclusive rights to market and distribute XTORO ® (finafloxacin otic suspension) 0.3 ...

XTORO is a New Chemical Entity that is FDA approved for the treatment of acute otitis externa, commonly known as "swimmer’s ear", caused by susceptible strains of Pseudomonas aeruginosa and ...

CBD gummies are easy to dose, portable, and discreet ... as a possible additional tool for anxiety — not a stand-alone solution. Another tester, Sydney Samuels, who tried them for more mild ...

NTPC Green Energy IPO GMP Today: NTPC Green Energy's IPO was fully subscribed by the third day, driven by strong interest from retail investors. The offering aims to raise Rs 10,000 crore to fund ...